Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Universal Health Services
UHS
$10.5B
| $17M | 0.01% |
114,010
-103,656
| -48% | -$14.9M |
|
|
ZEN
977
DELISTED
ZENDESK INC
ZEN
| $16.9M | 0.01% |
231,550
+183,984
| +387% | +$15.2M |
|
978
PUT
Microchip Technology
MCHP
$46B
| $16.9M | 0.01% |
363,000
-305,200
| -46% | -$13.8M |
|
979
Nasdaq
NDAQ
$52.9B
| $16.9M | 0.01% |
509,052
+16,935
| +3% | +$563K |
|
980
Thomson Reuters
TRI
$44.1B
| $16.8M | 0.01% |
238,002
+71,255
| +43% | +$5.06M |
|
981
PUT
Spotify
SPOT
$100B
| $16.7M | 0.01% |
146,900
-15,100
| -9% | -$2.13M |
|
982
Newell Brands
NWL
$2.56B
| $16.7M | 0.01% |
894,317
-132,634
| -13% | -$2.14M |
|
|
CZR
983
PUT
DELISTED
Caesars Entertainment Corporation
CZR
| $16.7M | 0.01% |
1,435,500
-600,700
| -30% | -$7.04M |
|
984
CALL
HF Sinclair
DINO
$14.5B
| $16.7M | 0.01% |
311,800
+5,600
| +2% | +$272K |
|
985
PUT
EOG Resources
EOG
$70.7B
| $16.7M | 0.01% |
225,300
+79,400
| +54% | +$6.43M |
|
986
PUT
Pinduoduo
PDD
$131B
| $16.7M | 0.01% |
518,800
-26,200
| -5% | -$700K |
|
987
Aramark
ARMK
$14.7B
| $16.7M | 0.01% |
530,618
+151,800
| +40% | +$4.27M |
|
988
CALL
Cigna
CI
$74.6B
| $16.7M | 0.01% |
109,896
+14,984
| +16% | +$2.44M |
|
|
WBA
989
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $16.7M | 0.01% |
301,500
-14,600
| -5% | -$782K |
|
|
CELG
990
PUT
DELISTED
Celgene Corp
CELG
| $16.6M | 0.01% |
167,500
-76,200
| -31% | -$7.24M |
|
991
Jacobs Solutions
J
$17B
| $16.6M | 0.01% |
219,562
+17,151
| +8% | +$1.23M |
|
992
Steris
STE
$23.1B
| $16.6M | 0.01% |
114,859
+67,047
| +140% | +$10M |
|
993
PUT
Lyft
LYFT
$6.63B
| $16.6M | 0.01% |
406,300
+122,400
| +43% | +$6.69M |
|
994
PUT
Marathon Petroleum
MPC
$83.7B
| $16.5M | 0.01% |
271,812
+21,900
| +9% | +$1.15M |
|
995
Fortinet
FTNT
$117B
| $16.5M | 0.01% |
1,073,740
-106,090
| -9% | -$1.72M |
|
|
DOCU
996
CALL
DocuSign
DOCU
$11.5B
| $16.4M | 0.01% |
265,500
+47,500
| +22% | +$2.49M |
|
997
CALL
HP
HPQ
$27.5B
| $16.4M | 0.01% |
868,800
+745,500
| +605% | +$14.6M |
|
998
Dentsply Sirona
XRAY
$2.43B
| $16.4M | 0.01% |
307,816
-31,654
| -9% | -$1.7M |
|
999
Tapestry
TPR
$32.8B
| $16.4M | 0.01% |
629,374
+87,762
| +16% | +$2.31M |
|
1000
CALL
Nutrien
NTR
$30.7B
| $16.3M | 0.01% |
326,900
+317,900
| +3,532% | +$16.2M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.